{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:38:50Z","timestamp":1772771930002,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"State Key Program of National Natural Science of China","award":["U1808202"],"award-info":[{"award-number":["U1808202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Brucella spp<\/jats:italic>. is an important zoonotic pathogen responsible for brucellosis in humans and animals.<jats:italic>Brucella abortus<\/jats:italic>A19 strain is a widespread vaccine in China. However, it has a drawback of residual virulence in animals and humans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, the BALB\/c mice were inoculated with either 100 \u03bcL PBS(control group, C group), 10<jats:sup>9<\/jats:sup>\u00a0CFU\/mL inactivated<jats:italic>B. abortus<\/jats:italic>A19 strain (I group), 10<jats:sup>5<\/jats:sup>\u00a0CFU\/mL (low-dose group, L group) 10<jats:sup>6<\/jats:sup>\u00a0CFU\/mL live<jats:italic>B. abortus<\/jats:italic>A19 strain (high-dose group, H group), or 10<jats:sup>5<\/jats:sup>\u00a0CFU\/mL live<jats:italic>B. abortus<\/jats:italic>A19 strain combined with 10<jats:sup>9<\/jats:sup>\u00a0CFU\/mL inactivated<jats:italic>B. abortus<\/jats:italic>A19 strain (LI group). Mice were challenged with<jats:italic>B. abortus<\/jats:italic>strain 2308 at 7\u00a0week post vaccination. Subsequently, the immune and protective efficacy of the vaccines were evaluated by measuring splenic bacterial burden, spleen weight, serum IgG, interferon-gamma (IFN-\u03b3), interleukin-4 (IL-4) percentage of CD4\u2009+\u2009and CD8\u2009+\u2009T cells of mice via bacterial isolation, weighing, ELISA and flow cytometry, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The splenic bacterial burden and spleen weight of the mice in group LI were mostly equivalent to the mice of group H. Moreover,<jats:italic>Brucella<\/jats:italic>-specific serum IgG, IFN-\u03b3, IL-4, and the percentage of CD4<jats:sup>+<\/jats:sup>and CD8<jats:sup>+<\/jats:sup>T cells of the LI group mice were similar to those of the H group. In the subsequent challenge test, both vaccines conferred protective immunity to wild-type (WT) 2308 strain. In addition, the levels of IL-4 and IFN-\u03b3, CD4<jats:sup>+<\/jats:sup>and CD8<jats:sup>+<\/jats:sup>T cells in these mice were similar to those of the mice in the H group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Combined immunization with low dose live vaccine and inactivated vaccine allowed to reduce the live<jats:italic>B. abortus<\/jats:italic>A19 vaccine, dose with an equivalent protection of the high-dose live vaccine.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-022-03229-0","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:03:35Z","timestamp":1648879415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combined immunization with inactivated vaccine reduces the dose of live B. abortus A19 vaccine"],"prefix":"10.1186","volume":"18","author":[{"given":"Chuan-Yu","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Song","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"issue":"1","key":"3229_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S1369-5274(00)00165-X","volume":"4","author":"ML Boschiroli","year":"2001","unstructured":"Boschiroli ML, Foulongne V, O\u2019Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol. 2001;4(1):58\u201364.","journal-title":"Curr Opin Microbiol"},{"issue":"3\u20134","key":"3229_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.vetmic.2009.06.021","volume":"140","author":"MN Seleem","year":"2010","unstructured":"Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010;140(3\u20134):392\u20138.","journal-title":"Vet Microbiol"},{"issue":"3","key":"3229_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0378-1135(02)00367-X","volume":"92","author":"TA Ficht","year":"2003","unstructured":"Ficht TA. Intracellular survival of Brucella: defining the link with persistence. Vet Microbiol. 2003;92(3):213\u201323.","journal-title":"Vet Microbiol"},{"issue":"1\u20134","key":"3229_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","volume":"90","author":"GG Schurig","year":"2002","unstructured":"Schurig GG, Sriranganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol. 2002;90(1\u20134):479\u201396.","journal-title":"Vet Microbiol"},{"issue":"1","key":"3229_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1051\/vetres:2003037","volume":"35","author":"I Moriy\u00f3n","year":"2004","unstructured":"Moriy\u00f3n I, Grill\u00f3 MJ, Monreal D, Gonz\u00e1lez D, Mar\u00edn C, L\u00f3pez-Go\u00f1i I, et al. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res. 2004;35(1):1\u201338.","journal-title":"Vet Res"},{"issue":"8","key":"3229_CR6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2460\/ajvr.1998.59.08.1016","volume":"59","author":"VR Lord","year":"1998","unstructured":"Lord VR, Schurig GG, Cherwonogrodzky JW, Marcano MJ, Melendez GE. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res. 1998;59(8):1016\u201320.","journal-title":"Am J Vet Res"},{"issue":"3","key":"3229_CR7","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/iai.64.3.1030-1034.1996","volume":"64","author":"MG Stevens","year":"1996","unstructured":"Stevens MG, Olsen SC. Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51. Infect Immun. 1996;64(3):1030\u20134.","journal-title":"Infect Immun"},{"issue":"12","key":"3229_CR8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2460\/ajvr.1998.59.12.1575","volume":"59","author":"PH Elzer","year":"1998","unstructured":"Elzer PH, Enright FM, Colby L, Hagius SD, Walker JV, Fatemi MB, et al. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Am J Vet Res. 1998;59(12):1575\u20138.","journal-title":"Am J Vet Res"},{"issue":"3","key":"3229_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.biologicals.2005.04.003","volume":"33","author":"F Mukherjee","year":"2005","unstructured":"Mukherjee F, Jain J, Grill\u00f3 MJ, Blasco JM, Nair M. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB\/c mice. Biologicals. 2005;33(3):153\u201360.","journal-title":"Biologicals"},{"issue":"2","key":"3229_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","volume":"28","author":"GG Schurig","year":"1991","unstructured":"Schurig GG, Roop RM, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991;28(2):171\u201388.","journal-title":"Vet Microbiol"},{"key":"3229_CR11","doi-asserted-by":"crossref","unstructured":"Arenas-Gamboa AM, Ficht TA, Kahl-Mcdonagh MM, Gomez G, Rice-Ficht AC. The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle. Infect Immun. 2009;77(2):877\u201384.","DOI":"10.1128\/IAI.01017-08"},{"key":"3229_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.micpath.2018.08.052","volume":"124","author":"Z Li","year":"2018","unstructured":"Li Z, Wang S, Zhang H, Xi L, Zhang J, Zhang X, et al. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant. Microb Pathog. 2018;124:250\u20137.","journal-title":"Microb Pathog"},{"issue":"2","key":"3229_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1128\/CVI.05321-11","volume":"19","author":"AM Arenas-Gamboa","year":"2012","unstructured":"Arenas-Gamboa AM, Rice-Ficht AC, Fan Y, Kahl-McDonagh MM, Ficht TA. Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-\/- mouse model. Clin Vaccine Immunol. 2012;19(2):249\u201360.","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"3229_CR14","first-page":"183","volume":"1","author":"SC Olsen","year":"2000","unstructured":"Olsen SC. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle. Vet Ther. 2000;1(3):183\u201391.","journal-title":"Vet Ther"},{"issue":"1","key":"3229_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.20506\/rst.26.1.1737","volume":"26","author":"J Lubroth","year":"2007","unstructured":"Lubroth J, Rweyemamu MM, Viljoen G, Diallo A, Dungu B, Amanfu W. Veterinary vaccines and their use in developing countries. Rev Sci Tech. 2007;26(1):179\u2013201.","journal-title":"Rev Sci Tech"},{"issue":"3","key":"3229_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1086\/375595","volume":"37","author":"RL Berkelman","year":"2003","unstructured":"Berkelman RL. Human illness associated with use of veterinary vaccines. Clin Infect Dis. 2003;37(3):407\u201314.","journal-title":"Clin Infect Dis"},{"issue":"25\u201326","key":"3229_CR17","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/j.vaccine.2004.02.041","volume":"22","author":"DA Ashford","year":"2004","unstructured":"Ashford DA, di Pietra J, Lingappa J, Woods C, Noll H, Neville B, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22(25\u201326):3435\u20139.","journal-title":"Vaccine"},{"issue":"1","key":"3229_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11250-014-0678-2","volume":"47","author":"P Chand","year":"2015","unstructured":"Chand P, Chhabra R, Nagra J. Vaccination of adult animals with a reduced dose of Brucella abortus S19 vaccine to control brucellosis on dairy farms in endemic areas of India. Trop Anim Health Prod. 2015;47(1):29\u201335.","journal-title":"Trop Anim Health Prod"},{"issue":"2","key":"3229_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/tbed.12018","volume":"61","author":"MN Aznar","year":"2014","unstructured":"Aznar MN, Samartino LE, Humblet MF, Saegerman C. Bovine brucellosis in Argentina and bordering countries: update. Transbound Emerg Dis. 2014;61(2):121\u201333.","journal-title":"Transbound Emerg Dis"},{"issue":"5","key":"3229_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0007-1935(85)90046-6","volume":"141","author":"FW Beckett","year":"1985","unstructured":"Beckett FW, MacDiarmid SC. The effect of reduced-dose Brucella abortus strain 19 vaccination in accredited dairy herds. Br Vet J. 1985;141(5):507\u201314.","journal-title":"Br Vet J"},{"issue":"5","key":"3229_CR21","doi-asserted-by":"publisher","first-page":"e0123374","DOI":"10.1371\/journal.pone.0123374","volume":"10","author":"AE Osman","year":"2015","unstructured":"Osman AE, Hassan AN, Ali AE, Abdoel TH, Smits HL. Brucella melitensis biovar 1 and brucella abortus S19 vaccine strain infections in milkers working at cattle farms in the Khartoum Area Sudan. PLoS One. 2015;10(5):e0123374-0123374.","journal-title":"PLoS One"},{"key":"3229_CR22","doi-asserted-by":"crossref","unstructured":"Baoshan L, Yinbo Y, Jingbo Z, Yi Z, Jianghua Y, Dawei C, et al. Combined nucleic acid assays for diagnosis of A19 vaccine-caused human brucellosis. Transbound Emerg Dis. 2021;68(2):368\u201374.","DOI":"10.1111\/tbed.13685"},{"issue":"1","key":"3229_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00253-019-10106-8","volume":"104","author":"Z Hongzhuan","year":"2020","unstructured":"Hongzhuan Z, Ying T, Xia S, Jinsong G, Zhenhua Z, Beiyu J, et al. Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy. Appl Microbiol Biotechnol. 2020;104(1):107\u201317.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"11","key":"3229_CR24","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1128\/IAI.71.11.6264-6269.2003","volume":"71","author":"JE Ugalde","year":"2003","unstructured":"Ugalde JE, Comerci DJ, Leguizam\u00f3n MS, Ugalde RA. Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine. Infect Immun. 2003;71(11):6264\u20139.","journal-title":"Infect Immun"},{"issue":"6","key":"3229_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1139\/W09-017","volume":"55","author":"W Wu","year":"2009","unstructured":"Wu W, Weigand L, Mendez S. The IL-6-deficient mouse exhibits impaired lymphocytic responses to a vaccine combining live Leishmania major and CpG oligodeoxynucleotides. Can J Microbiol. 2009;55(6):705\u201313.","journal-title":"Can J Microbiol"},{"issue":"1","key":"3229_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1286-4579(00)01350-2","volume":"3","author":"B Golding","year":"2001","unstructured":"Golding B, Scott DE, Scharf O, Huang LY, Zaitseva M, Lapham C, et al. Immunity and protection against Brucella abortus. Microbes Infect. 2001;3(1):43\u20138.","journal-title":"Microbes Infect"},{"issue":"5","key":"3229_CR27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.4049\/jimmunol.144.5.1629","volume":"144","author":"NE Street","year":"1990","unstructured":"Street NE, Schumacher JH, Fong TA, Bass H, Fiorentino DF, Leverah JA, et al. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol. 1990;144(5):1629\u201339.","journal-title":"J Immunol"},{"issue":"4","key":"3229_CR28","first-page":"659","volume":"83","author":"SC Oliveira","year":"1994","unstructured":"Oliveira SC, Zhu Y, Splitter GA. Recombinant L7\/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology. 1994;83(4):659\u201364.","journal-title":"Immunology"},{"issue":"4","key":"3229_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","volume":"103","author":"EA Murphy","year":"2001","unstructured":"Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice. Immunology. 2001;103(4):511\u20138.","journal-title":"Immunology"},{"issue":"12","key":"3229_CR30","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1128\/IAI.00761-12","volume":"80","author":"MA Vitry","year":"2012","unstructured":"Vitry MA, De Trez C, Goriely S, Dumoutier L, Akira S, Ryffel B, et al. Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun. 2012;80(12):4271\u201380.","journal-title":"Infect Immun"},{"issue":"2","key":"3229_CR31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.4049\/jimmunol.180.2.1080","volume":"180","author":"GC Macedo","year":"2008","unstructured":"Macedo GC, Magnani DM, Carvalho NB, Bruna-Romero O, Gazzinelli RT, Oliveira SC. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol. 2008;180(2):1080\u20137.","journal-title":"J Immunol"},{"key":"3229_CR32","doi-asserted-by":"publisher","first-page":"686919","DOI":"10.1155\/2013\/686919","volume":"2013","author":"SL Yingst","year":"2013","unstructured":"Yingst SL, Izadjoo M, Hoover DL. CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis. Clin Dev Immunol. 2013;2013:686919\u2013686919.","journal-title":"Clin Dev Immunol"},{"issue":"7","key":"3229_CR33","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1128\/IAI.01957-05","volume":"74","author":"X Yang","year":"2006","unstructured":"Yang X, Becker T, Walters N, Pascual DW. Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun. 2006;74(7):3874\u20139.","journal-title":"Infect Immun"},{"issue":"19","key":"3229_CR34","doi-asserted-by":"publisher","first-page":"13906","DOI":"10.1074\/jbc.M113.459305","volume":"288","author":"HS Kim","year":"2013","unstructured":"Kim HS, Caswell CC, Foreman R, Roop RM, Crosson S. The Brucella abortus general stress response system regulates chronic mammalian infection and is controlled by phosphorylation and proteolysis. J Biol Chem. 2013;288(19):13906\u201316.","journal-title":"J Biol Chem"},{"issue":"28","key":"3229_CR35","doi-asserted-by":"publisher","first-page":"E3709","DOI":"10.1073\/pnas.1503118112","volume":"112","author":"JW Willett","year":"2015","unstructured":"Willett JW, Herrou J, Briegel A, Rotskoff G, Crosson S. Structural asymmetry in a conserved signaling system that regulates division, replication, and virulence of an intracellular pathogen. Proc Natl Acad Sci U S A. 2015;112(28):E3709\u201318.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-022-03229-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T13:34:12Z","timestamp":1726925652000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-022-03229-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3229"],"URL":"https:\/\/doi.org\/10.1186\/s12917-022-03229-0","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the animal welfare and ethics committee of TECON Biology Co., Ltd. (TBCA20-014). All animal experiments were performed in accordance with the relevant guidelines and regulations and the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests in this section.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}